(Q33732870)

English

The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

multicenter clinical trial

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hely MA

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Morris JG

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Reid WG

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

O'Sullivan DJ

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Williamson PM

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Rail D

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Broe GA

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Margrie S

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 August 1994

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

903-910

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

The impact of treatment with levodopa on Parkinson's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

Sinemet and the treatment of Parkinsonism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

Bromocriptine in Parkinsonism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

Combined bromocriptine-levodopa therapy early in Parkinson's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

Clinical importance of D-1 and D-2 receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

The neuropsychology of de novo patients with idiopathic Parkinson's disease: the effects of age of onset.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

The occurrence of motor fluctuations in parkinsonian patients treated long term with levodopa: role of early treatment and disease progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

Dopamine agonists used as monotherapy in de novo PD patients: comparisons with selegiline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

Six-year results of treatment with levodopa plus benzerazide in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

A Qualitative Discrepancy between Censored Data Rank Tests

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1073071

21 June 2018

Physiology and pharmacology of dopamine D2-receptors: their implications in dopamine-substitute therapy for Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8057111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term bromocriptine treatment of de novo patients with Parkinson's disease. A seven-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/8057111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A nationwide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. The fourth interim report

1 reference

https://pubmed.ncbi.nlm.nih.gov/8057111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability of the Columbia scale for assessing signs of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8057111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A method for evaluating disability in patients with Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8057111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transient responses of the normal and diseased motor system to sudden load changes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8057111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bromocriptine: low-dose therapy in Parkinson disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8057111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8057111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic low-dose levodopa therapy in Parkinson's disease: an argument for delaying levodopa therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8057111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Result of chronic levodopa therapy and its modification by bromocriptine in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8057111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of early dopa treatment in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8057111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bromocriptine and the clinical spectrum of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8057111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.57.8.903

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33732870&oldid=1615782077"